Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity

• Autores: Szwejser-Zawislak, Ewa; Wilk, Mieszko M.; Piszczek, Piotr; Krawczyk, Justyna; Wilczy?ska, Daria; Hozbor, Daniela Flavia
• Año de publicación: 2022
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: ACELLULAR PERTUSSIS VACCINE; BORDETELLA PERTUSSIS; DTAP; DTWP; PERTUSSIS; TDAP; WHOLE CELL PERTUSSIS VACCINE
• Institución: Consejo Nacional de Investigaciones Científicas y Técnicas

After the pertussis vaccine had been introduced in the 1940s and was shown to be very successful in reducing the morbidity and mortality associated with the disease, the possibility of improving both vaccine composition and vaccination schedules has become the subject of continuous interest. As a result, we are witnessing a considerable heterogeneity in pertussis vaccination policies, which remains beyond universal consensus. Many pertussis-related deaths still occur in low- and middle-income countries; however, these deaths are attributable to gaps in vaccination coverage and limited access to healthcare in these countries, rather than to the poor efficacy of the first generation of pertussis vaccine consisting in inactivated and detoxified whole cell pathogen (wP). In many, particularly high-income countries, a switch was made in the 1990s to the use of acellular pertussis (aP) vaccine, to reduce the rate of post-vaccination adverse events and thereby achieve a higher percentage of children vaccinated. However the epidemiological data collected over the past few decades, even in those high-income countries, show an increase in pertussis prevalence and morbidity rates, triggering a wide-ranging debate on the causes of pertussis resurgence and the effectiveness of current pertussis prevention strategies, as well as on the efficacy of available pertussis vaccines and immunization schedules. The current article presents a systematic review of scientific reports on the evaluation of the use of whole-cell and acellular pertussis vaccines, in the context of long-term immunity and vaccines efficacy.
Fil: Szwejser-Zawislak, Ewa. Institute Of Biotechnology Of Serums And Vaccines Biomed; Polonia
Fil: Wilk, Mieszko M.. Uniwersytet Jagielloński; Polonia
Fil: Piszczek, Piotr. Institute Of Biotechnology Of Serums And Vaccines Biomed; Polonia
Fil: Krawczyk, Justyna. Institute Of Biotechnology Of Serums And Vaccines Biomed; Polonia
Fil: Wilczy?ska, Daria. Institute Of Biotechnology Of Serums And Vaccines Biomed; Polonia
Fil: Hozbor, Daniela Flavia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Biotecnología y Biología Molecular. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Biotecnología y Biología Molecular; Argentina